A study, published by the Journal of Clinical Oncology, of about 2,500 women has found that those who have inherited mutations in BRCA1 or BRCA2 genes and who have been diagnosed with breast cancer can lower their risk for developing a new breast cancer by taking tamoxifen.
Read more, including the abstract.
Study: Tamoxifen reduces future risk of breast cancer in women with genetic predisposition who have had a tumor
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
